HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Depositions Reveal Crawford’s Prominent Role In Plan B Switch Review

This article was originally published in The Tan Sheet

Executive Summary

The role of high-level FDA officials in the review of Barr Labs' Rx-to-OTC switch application for Plan B was required by the "high-profile" nature of the NDA, according to Center for Drug Evaluation & Research Director Steven Galson

You may also be interested in...



Crawford Pleads Guilty Of Failing To Disclose Stocks In Firms FDA Regulates

Former FDA Commissioner Lester Crawford on Oct. 17 pleaded guilty in federal court to charges related to owning stocks in companies regulated by the agency

CDER Officials Testify On Behind-The-Scenes Maneuvers In Plan B Rejection

The initial rejection of Barr's Rx-to-OTC switch application for Plan B may have been intended to lead eventually to a restricted approval, according to deposition testimony from FDA officials

Plan B Draws Criticism During Von Eschenbach Confirmation Hearing

FDA's recent request to meet with Barr Labs about the proposed OTC sale of Plan B has done little to quell criticisms from Senate Democrats concerning the agency's extensive delays in issuing a decision on the Rx-to-OTC switch application

Related Content

Topics

UsernamePublicRestriction

Register

RS125479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel